Skip to content

ReLIA

by ReLIA Biotechnologies (Jiangsu), Inc. China EUDAMED

Ref RF16133-20T

EMDN W0102050215

Regulatory status

as of 24 Oct 2026

RegionAuthorizationNumberDateStatus
European UnionCE/IVDD NumberB-06971354100279 Basic UDI-DIDate21 May 2026RegisteredStatusActive

Coverage

1 jurisdiction

SwedenFinlandFinlandSwedenFinlandFinlandSwedenSwedenLatviaEstoniaDenmarkLithuaniaIrelandNetherlandsGermanyGermanyPolandPolandFranceBelgiumLuxembourgCzech RepublicSlovakiaPolandFranceFranceAustriaHungaryRomaniaFranceFranceSloveniaBulgariaPortugalSpainSpainItalySpainSpainCroatiaGreeceMaltaCyprus
  • Expiring (legacy directive)
  • Not covered

European Union — CE/IVDD Expiring (legacy directive)

Certificates: none listed in EUDAMED

Specification

EUDAMED · synced 23 Oct 2026

Device Name
Anti-Mullerian Hormone Test (Fluorescence Immunoassay)
Model / Reference
RF16133-20T
Primary DI / UDI-DI
06971354100279
Basic UDI-DI
B-06971354100279
EMDN Code
W0102050215 Anti-mullerian hormone
Device Class
Class IVD General
Market of Registration
Slovenia

Manufacturer details

EUDAMED SRN
CN-MF-000042042
Authorised representative
Luxus Lebenswelt GmbH DE-AR-000005110

Other devices from ReLIA Biotechnologies (Jiangsu), Inc.

  • ReLIA

    IVD General

  • ReLIA

    IVD General

  • ReLIA

    IVD General

  • ReLIA

    IVD General

  • ReLIA

    IVD General

  • ReLIA

    IVD General

See all devices from ReLIA Biotechnologies (Jiangsu), Inc. →

Properties & raw data

Show properties, registry sources and raw records
  • Animal Tissues
  • Reagent
  • Professional Testing
Other properties (7)
  • Sterile: No
  • Human Tissues: No
  • Microbial Substances: No
  • Self Testing: No
  • Near-Patient Testing: No
  • Companion Diagnostics: No
  • Surgical Instrument: No

Sources (1)

  • EUDAMED c66c4499-2f9f-45d9-9356-bb39b55ff950 61 fields · synced 23 Oct 2026